WCLC 2016 – Lung Cancer

Challenges in Managing Toxicities

Challenges in Managing Toxicities

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

My Practice: Roles and Responsibilities

My Practice: Roles and Responsibilities

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Immunotherapies and Lung Cancer

Immunotherapies and Lung Cancer

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Choosing the Right Therapy for Patients with NSCLC

Choosing the Right Therapy for Patients with NSCLC

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Differences in NSCLC Patient Populations

Differences in NSCLC Patient Populations

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

ALK Gene Rearrangement and PD-L1 Expression

ALK Gene Rearrangement and PD-L1 Expression

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

A Look at PD-1 and PD-L1 Inhibitors

A Look at PD-1 and PD-L1 Inhibitors

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Shifts in Lung Cancer Treatment

Shifts in Lung Cancer Treatment

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Common Presenting Factors for NSCLC

Common Presenting Factors for NSCLC

FEATURING:

Dr. Edward Garon

Lung Cancer, WCLC 2016 – Lung Cancer

Page 1 of 2

1
2